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COMPLICACIONES CRÓNICAS RELACIONADAS CON TRATAMIENTO DE HEMODIÁLISIS EN HIPERTENSOS: REVISIÓN 
INTEGRADORA 
Oleci Pereira Frota1, Nájla Moreira Amaral Borges2 
ABSTRACT 
Objective: To identify and analyze the main hemodialysis treatment-related chronic complications in hypertensive 
patients, as well as the prevention strategies. Method: This is an integrative literature review conducted in the VHL, 
BDENF, MEDLINE and SCIELO databases, by using the descriptors Kidney Failure, chronic, Hypertension, Hemodialysis, 
Cardiovascular diseases. Results: The main complications identified were: left ventricular hypertrophy (67.8%), heart 
failure (20.7%), heart arrhythmias (36.3%) and coronary artery disease (33.4%). Other factors also influence in these 
complications, namely: anemia, diabetes mellitus, dyslipidemias and the hydroelectrolytic changes. The appropriate 
monitoring of the blood pressure, the increased duration or frequency of the hemodialysis sessions, the use of 
antihypertensive and the early intervention in the modifiable risk factors are measures that control the evolution of 
these complications. Conclusion: The High Blood Pressure is the main risk factor of the cardiovascular complications 
and a chronic state of patients undergoing hemodialysis treatment. Descriptors: Chronic Kidney Failure, Hypertension, 
Kidney Dialysis, Complications, Cardiovascular Diseases.  
 
RESUMO 
Objetivo: Identificar e analisar as principais complicações crônicas relacionadas ao tratamento hemodialítico em 
pacientes hipertensos, bem como as estratégias de prevenção. Método: Trata-se de uma revisão integrativa da 
literatura realizada nos bancos BVS, BDENF, MEDLINE e SCIELO, utilizando os descritores Insuficiência renal crônica, 
Hipertensão, Hemodiálise e Doenças cardiovasculares. Resultados: As principais complicações levantadas foram: 
hipertrofia ventricular esquerda (67,8%), insuficiência cardíaca (20,7%), arritmias cardíacas (36,3%) e doença arterial 
coronariana (33,4%). Outros fatores também influenciam nessas complicações, a saber: anemia, diabetes mellitus, 
dislipidemias e as alterações hidroeletrolíticas. O monitoramento adequado da pressão arterial, o aumento da duração 
ou frequência das sessões de hemodiálise, o uso de anti-hipertensivos e a intervenção precoce nos fatores de risco 
modificáveis são medidas que controlam a evolução dessas complicações. Conclusão: A hipertensão arterial é o 
principal fator de risco para as complicações cardiovasculares e um quadro crônico nos pacientes em hemodiálise. 
Descritores: Insuficiência Renal Crônica, Hipertensão, Diálise Renal, Complicações, Doenças Cardiovasculares.  
 
RESUMEN 
Objetivo: Identificar y analizar las principales complicaciones relacionadas con tratamiento de hemodiálisis en 
hipertensos, y las estrategias de prevención. Método: Revisión integradora de la literatura realizada en las bases BVS, 
BDENF, MEDLINE y SCIELO utilizando los descriptores Insuficiencia Renal Crónica, Hipertensión, Diálisis Renal, 
Enfermedades Cardiovasculares. Resultados. Las principales complicaciones identificadas fueron: hipertrofia 
ventricular izquierda (67,8%), insuficiencia cardíaca (20,7%), arritmias cardíacas (36,3%) y enfermedad arterial 
coronaria (33,4%). También influencian en esas complicaciones anemia, Diabetes Mellitus, dislipidemias y las 
alteraciones hidroelectrolíticas. La monitorización adecuada de la presión arterial, el aumento de la duración o de la 
frecuencia de las sesiones de hemodiálisis, el uso de antihipertensivos y la intervención precoz en factores de riesgo 
modificables son medidas que controlan la evolución de esas complicaciones. Conclusión: La Hipertensión Arterial es el 
principal factor de riesgo de las complicaciones cardiovasculares y un cuadro crónico en los pacientes en hemodiálisis. 
Descriptores: Insuficiencia Insuficiencia Renal Crónica, Hipertensión, Diálisis renal, Complicaciones, Enfermedades 
cardiovasculares. 
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In the last few decades, the deployment of 
specific sanitary measures, the advances in drug 
therapy, the scientific and technological 
development and increased life expectancy have 
been contributing to the population aging. The 
industrialization process, the disorderly growth of 
large cities, together with lifestyle changes, have 
made the population more susceptible to chronic 
and degenerative diseases.1-3 
Chronic kidney failure (CKF), which is 
considered a chronic and degenerative disease, is 
a clinical syndrome caused by progressive and 
irreversible loss of kidney function. It results in 
local and systemic changes such as bone, mental, 
sleep rhythm, intraocular pressure and heart 
dysfunctions, besides anasarca and systemic 
arterial hypertension (SAH).1,2,4-6 
Nowadays, hemodialysis is the most often 
kidney replacement therapy used as a treatment 
for CKF cases, which requires a stable heart 
function from the patient.7 Such a therapy, over 
the years, has been providing greater longevity6 to 
patients, being that it is considered safe and well 
tolerated by patients with Chronic Kidney Disease 
(CKD).8 Nonetheless, the complications inherent in 
this process are still frequent, accounting for 
significant morbidity and mortality amounts.3,9  
It is known that arterial hypotension, 
cramps, nausea, vomiting, headache, chest pain, 
back pain, itching, fever and chills are the main 
acute complications related to hemodialysis 
sessions.9 However, there are important chronic 
complications related to the SAH establishment, 
since, at least, 80% of patients who start 
hemodialysis treatment are hypertensive.10-12 
SAH associated with CKD arises from 
multifactorial11 pathophysiological mechanisms, 
with an emphasis to the hydrosaline overload, as 
well as renin-angiotensin-aldosterone and 
sympathetic nervous systems hyperactivation, 
endothelial dysfunction and chronic 
hyperparathyroidism.13 Thus, SAH is considered a 
common complication in patients with CKF treated 
with hemodialysis and also a risk factor for 
development of chronic complications, especially 
the cardiovascular ones14-16, given the high 
mortality rate arising from these complications, 
even, surpassing voluntary dropouts to the 
hemodialysis treatment.19  
In hemodialysis patients with chronic 
kidney disease, SAH causes structural changes in 
the cardiovascular system so much earlier in 
comparison with hypertensive patients without 
kidney disease. This is due to the CKF-related 
conditions such as overloaded volume, anemia, 
presence of uremic toxins and, even, the 
hemodialysis itself make the patient more likely to 
develop these complications. 20 Other factors that 
might interfere with their occurrence are the 
presence of diabetes mellitus (DM), increased 
creatinine levels, hyperparathyroidism, increased 
homocysteine levels, oxidative stress and elevated 
C-reactive21 protein plasma concentration, besides 
smoking habit, obesity and dyslipidemia.22,23 
Despite all this knowledge, the main 
clinical complications arising from these 
physiological changes caused by hemodialysis and 
SAH are not particularly summarized and discussed 
in literature, as well as the preventive measures 
to these complications. Based on the 
aforementioned considerations, the aim of this 
study was to identify and analyze the main chronic 
complications arising from the hemodialysis 
treatment related to SAH, by pointing out to 
prevention strategies for such complications. 
This current study might be justified 
because the synthetic gathering of these 
knowledge sources is an important step to support 
the work of the nursing staff in an independent 
way or along with the multidisciplinary healthcare 
staff, by seeking improvements in the quality of 
INTRODUCTION 
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the provided services, complications prevention 
and adherence to the measures recommended by 
the professionals and patients themselves, besides 
encouraging further researches and teaching-
learning shares. 
 
 
 
 
This is an integrative literature review. 
This bibliographic review method allows a holistic 
understanding on the studied phenomenon, 
considering that it admits non-experimental and 
experimental studies about a particular study 
field. Furthermore, it enables the association 
between the theoretical and the empirical 
knowledge, as well as the inclusion of a wide 
range of purposes: defining the ideas, theories 
review and evidence, besides the analysis of 
problems in the set of rules of how to proceed in 
order to produce scientific knowledge about a 
particular theme.24 
In this review, we have adopted the model 
proposed by the authors Souza, Carvalho and 
Silva25, which detail the production process of this 
study type in six stages: 1) defining the guiding 
question, 2) search of the literature, 3) data 
collection; 4) critical analysis of the included 
studies, 5) results discussion, and 6) integrative 
review presentation. Thus, as a starting point, the 
following question was formulated: “What are the 
main chronic complications related to the 
hemodialysis treatment in hypertensive patients 
and their respective prevention strategies”? 
We have conducted a search in the 
electronic databases of the VHL, Brazilian Nursing 
Database (BDENF), Medical Literature Analysis and 
Retrieval System Online (MEDLINE) and Scientific 
Electronic Library Online (SciELO). Based on the 
health terminology MeSH, from the VHL, during 
the search, the controlled descriptors were used: 
complicações, insuficiência renal crônica, 
hipertensão arterial, hemodiálise, and their 
respective English versions.  
Inclusion criteria established for the 
literature selection were: paper published 
between the period from 2001 to 2011, written in 
Portuguese, English or Spanish; showing resume 
for initial analysis and being available in its full 
version, by the databases themselves or by CAPES 
Periodicals Portal; besides discussing about the 
issue at stake. We have excluded theses, 
dissertations and educational stuff. 
For extracting the data from the selected 
papers, we have used a previously validated tool 
in the literature.26 Such a tool allows us to 
separately assess each item, by using a form that 
includes the following items: paper identification, 
methodological features of the study, assessment 
of the method accuracy, measured interventions 
and found outcomes. 
Firstly, we carried out a pre-analysis of 
papers through critical reading of titles and 
detailed study of their respective resumo, 
abstract or resumén. After identification, 
possession and exhaustive exploration of the 
works, i.e., reading and rereading, we have 
selected those that actually mattered to the 
study. From the pre-analysis, we have selected 
104 papers relevant to the issue. But, after 
applying the selection criteria, only 58 were 
selected and composed the sample. 
 
 
 
We have found papers in three languages: 
Portuguese, English and Spanish, totaling 58 works 
published from 2001 to 2011. The most used 
descriptors by the authors of the papers were 
chronic kidney failure, end-stage kidney disease, 
hypertension, hemodialysis, epidemiology, left 
ventricular hypertrophy and cardiovascular 
diseases, being that some of these studies made 
use of kidney units and outpatient clinics as 
research fields. 
METHODOLOGY 
 
RESULTS AND DISCUSSION 
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Table 1 shows the average prevalence of 
the main chronic complications manifested in 
patients with SAH and CKF on hemodialysis 
treatment included in the reviewed studies and 
that mentioned the found values. 
Table 1: Average prevalence of the main chronic 
complications arising from the association between 
hemodialysis treatment and SAH 
Complications 
Average 
prevalence (%) 
Left Ventricular Hypertrophy 67,8 
Heart Failure 20,7 
Heart Arrhythmias 36,3 
Coronary Artery Disease 33,4 
Myocardial Ischemia 18,6 
Peripheral Vascular Disease 12,9 
Stroke 9,6 
Myocardial Infarction 6,3 
 
Regarding the preventive measures, the 
most reported in the reviewed studies were: 
increased time of duration or frequency of 
hemodialysis sessions; greater use of 
antihypertensive drug therapy; sodium and fluid 
intake restriction; heart function control; early 
referral and monitoring by nephrologists, as well 
as control and intervention in risk factors and 
constant monitoring of blood pressure.10,20,27-29 
Each one with specific action, however, all with 
one purpose: improving blood pressure and 
prevent or delay the progression of cardiovascular 
complications.  
 
Left Ventricular Hypertrophy 
Left ventricular hypertrophy (LVH) is the 
most prevalent heart abnormality in patients on 
regular hemodialysis.15,27 The prevalence found in 
this study was lower in comparison to others. As 
an example, a bibliographic22 review research has 
found that 94% of hemodialysis patients were at 
high risk for LVH. This complication is a 
consequence of both of SAH and the overloaded 
volume18,28, which causes increased after-load and 
heart work.20  
In addition to SAH, there are other risk 
factors for the development of LVH such as: 
advanced age, hemoglobin level and/or anemia22 
and parathyroid hormone level.29 A study 
conducted with children with CKD records that 
anemia correction proved to be a factor able to 
significantly reduce the ventricular mass index in 
those hearts affected by LVH.  
Furthermore, the lack of hemodialysis 
patient adherence to healthy lifestyles and limited 
consumption of sodium and water also contribute 
to the occurrence of dilated cardiomyopathies of 
this clientele.14 Some authors17,29 argues that a 
better volume control and of BP can revert LVH. 
Accordingly, some peridialitic measures are 
recommended, such as the thorough management 
of interdialytic19 weight gain and extension of the 
hemodialysis sessions.10 
Heart Failure 
Heart failure (HF) is another cardiovascular 
complication arising from the hemodialysis chronic 
treatment. In this study, it has reached an average 
prevalence of 20.7%, although the reviewed 
studies present pretty diversified values. For 
example, a research conducted in a nephrology28 
service, in Spain, found a prevalence of 13.9%; 
another30 methodologically very similar research, 
held in Japan, but in a cardiology service, found 
that 27% of hemodialysis patients showed HF. 
However, in several studies22,29, HF was the 
primary cause of death in patients treated with 
hemodialysis. 
HF linked to SAH constitutes a strong risk 
factor, both for hemodialysis patients and for the 
population at large.28,31 With the CKF progression 
and long-term hemodialysis treatment, the 
overloaded volume and pressure, the uremia 
clinical picture and hydroelectrolytic changes 
become more prevalent, by alarmingly increasing 
hypertension cases and inducing the onset of 
ISSN 2175-5361                                                                                DOI: 10.9789/2175-5361.2013v5n2p3828  
                                                                                                                                                                                                                                                                                                         
Frota OP, Borges NMA                                                                             Hemodialysis Treatment-related… 
                                                   
R. pesq.: cuid. fundam. online 2013. abr./jun. 5(2):3828-36 
3832 
cardiovascular changes. Regardless of the 
established complication, all of them shall result 
in HF.20 
Low hemoglobin levels (<10g/dl) also 
increase the susceptibility to HF.31 This is due to 
the decreased delivery of oxygen to all tissues, 
especially to the myocardium discussed herein, 
which hinders the heart work, since the number of 
hemoglobin cells carrier of oxygen is sub-optimal 
(27%).21 Another risk factor is the occurrence of 
DM, whereas diabetic and hypertensive patients 
have a high incidence of HF.28,31 
Heart Arrhythmias 
Heart arrhythmia is another complication 
that can arise over the hemodialysis treatment. In 
this study, the average prevalence was of 36.3%, 
however, this value ranged from 21%8,18  to 70%30 
among the analyzed studies. Arrhythmias are 
present in most investigations about the 
cardiovascular complications and are frequently 
observed in end-stage CKD patients, as well as 
being responsible for high rates of sudden 
death.16,29 
Heart arrhythmias are resulting from acute 
changes in serum electrolyte levels in plasma20 
and stressed removal of fluid during the 
hemodialysis27 accomplishment, being that these 
variations are common in advanced CKD patients. 
When the hemodialysis patient is hypertensive, 
the removal of fluids and electrolytes is justified 
by the hydrosaline retention, which makes the 
patient more susceptible to electrolytic changes, 
since this removal decreases the circulating blood 
volume, by contributing to the onset of 
arrhythmias.20,27 Among these changes in serum 
electrolyte levels during these conditions, it 
should be mentioned those related to potassium 
ions (K+), calcium (Ca2+), magnesium (Mg2+), and 
phosphate (PO4
2).27 
The occurrence of arrhythmias can be 
promoted by other risk factors, including: male 
gender, advanced age, presence of SAH and/or 
diabetes, hypoxemia occurrence, underlying 
cardiovascular condition20,27, as well as presence 
of anemia and LVH.29 About 70% of hypertensive 
and 91% of diabetics patients, both on 
hemodialysis treatment, showed several degrees 
and types of arrhythmias and other heart 
problems, such as LVH and myocardial ischemia.27 
A Recent bibliographic review29 involving 452 
pediatric patients on hemodialysis treatment 
found that among heart events, arrhythmia was 
the most common in this clientele, by showing 
that hemodialysis children with CKD might also 
develop arrhythmias. 
Coronary Artery Disease 
Coronary artery disease (CAD) is a relevant 
complication in the general population and is 
present in hemodialysis patients, mainly, due to 
the sustained increase of blood pressure.14,15 The 
average prevalence of 33.4% was lower in relation 
the values found in other studies.22,32 
Nevertheless, some researches15,28 have reported 
numbers lower than 20% for CAD cases, especially 
regarding this clientele.  
Its development in hemodialysis patients 
who have SAH happens because of cardiovascular 
changes, which promote the onset of lesions. 
Changes such as hardening and thickening of the 
arterial walls, calcification of the coronary 
arteries, decreased arterial wall compliance and 
disorders of calcium and phosphorus metabolizing, 
not only increases blood pressure, but requires 
accelerated CAD progression.29 
Others 
Complications such as heart ischemia, 
myocardial infarction, stroke and peripheral 
vascular disease might also be consequences of 
the association between hemodialysis and SAH. In 
this study, the values obtained for all these 
conditions were lower than 20%, being similar to 
those obtained in other surveys.8,15,32 Nonetheless, 
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higher percentages are reported in the literature. 
A Brazilian research22 conducted at the Instituto 
do Coração (São Paulo) with hemodialysis patients 
found that 28% of them had peripheral vascular 
disease. A study30 conducted in Nagoya (Japan) 
monitored 100 patients subjected to hemodialysis 
treatment for at least five years, among the 
results, it is should be highlighted that 33% had 
ischemic heart. 
Associated with SAH, risk factors such as 
DM, dyslipidemias, anemia and 
hyperparathyroidism, contribute to the 
development of cardiovascular lesions and to the 
low heart variability rate.32 The presence of DM 
among hemodialysis patients increases the 
incidence, prevalence and severity of CAD.20,22 A 
research developed in hemodialysis centers in 
Spain found that diabetic patients had higher rates 
of CAD (20.8%) in comparison with non-diabetic 
patients (16.7%).28  
Lipid metabolism disorders early occur 
during the CKD course and are enhanced with a 
long-term hemodialysis treatment. Accordingly, 
patients who made use of long-term hemodialysis 
have low levels of HDL and high levels of oxidized 
LDL and triglycerides21,28, and it has a positive 
effect on the atherogenesis process.20 Hence, 
pharmacological treatment with statins is often 
introduced, since, besides reducing the total 
cholesterol levels, have anti-inflammatory effects 
which, in turn, delay the CKD progression.28,33 
It is noteworthy that changes as DM, 
hyperphosphatemia, disorders of calcium and 
phosphorus metabolism, besides dyslipidemias and 
anemia, foster the onset of stroke, peripheral 
vascular disease and heart ischemia.10,12,15,29 DM, 
in particular, contributes to high incidence of 
arteriopathies28, while hyperphosphatemia 
increases the risk of calcification and hardening of 
the arteries, heart34 ischemia and other adverse 
cardiovascular events.29 
Preventive measures 
SAH is a relevant risk factor for the onset 
of cardiovascular diseases16, besides being very 
prevalent among patients subjected to the chronic 
hemodialysis treatment.10,11 In this study, the 
majority of the raised cardiovascular 
complications have shown SAH as one of their 
main determinants. 
Accordingly, the use of antihypertensive 
drugs has been widely implemented. More than 
50% of hemodialysis patients make use of this 
pharmacological group, being that the main 
prescribed drugs are: angiotensin-converting 
enzyme inhibitors (ACEI), angiotensin receptors 
blockers, calcium channel blockers, alpha and 
beta-blockers, diuretics14,31 and vasodilators.28 
Even with the majority of patients being treated 
with antihypertensive drugs, the number of 
hypertensive patients with blood pressure above 
130/80 mmHg is considerable, which indicates the 
need to implement preventative measures. 
In fact, longer hemodialysis sessions, 
increased the number of sessions and the sodium 
and fluid restriction in diet reduce hydric overload 
and hypernatremia; the use of antihypertensive 
drugs inhibits fluid retention and vasoconstriction; 
the thorough control over the heart function 
enables the early detection of myocardial and 
vascular changes; the early referral to the 
nephrologist might prevent the CKD evolution to 
the end-stage; and the intervention on the risk 
factors might be performed through the lipids 
level control, anemia treatment with recombinant 
erythropoietin and iron, statin usage, absenteeism 
from alcohol and tobacco, besides the 
hyperparathyroidism, hyperphosphatemia and 
metabolic disorders of calcium and phosphorus 
treatments.10,14,16,31 
Importantly, the success of these measures 
is directly dependent on the implementation of 
health education strategies adopted by the 
multidisciplinary team which takes care of these 
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patients. Health education, one of the main 
nursing actions in the health production process, 
besides facilitating patient understanding about 
the disease, its treatment forms and 
consequences, stimulates its participation in the 
applicability and choice of measures aimed at 
preventing and delaying the development of 
chronic complications arising from the relationship 
among CKF, hemodialysis treatment and SAH, thus 
promoting a better adherence to the treatment 
and lifestyle changes. 
 
 
From the literature review, we might 
conclude that SAH, chronic condition fairly 
common in hemodialysis patients, is a relevant 
determinant to the development of chronic 
complications. Cardiovascular diseases are 
highlighted as predominant, being that the main 
ones are: left ventricular hypertrophy, heart 
failure, heart arrhythmias and coronary artery 
disease. Nonetheless, SAH depends on the 
interrelation with a set of risk factors for that 
these impairments prevalently take place.  
Among the preventive measures to these 
complications, it should be highlighted the 
effective blood pressure control, control and 
treatment of risk factors and appropriate use of 
antihypertensive drugs. But, for this purpose, the 
multidisciplinary team should devote special 
attention to health education, which serves as a 
mainspring for that the patient assumes, actually, 
the responsibility for its treatment and life. 
 
 
 
1. Barbosa DA, Gunji CK, Bittencourt ARC, 
Belasco AGS, Diccini S, Vattimo F, et al. Co-
morbidade e mortalidade de pacientes em início 
de diálise. Acta Paul Enferm. 2006;19(3):304-9. 
2. Fava SMCL, Oliveira AA, Vitor EM, Damasceno 
DD, Libânio SIC. Complicações mais frequentes 
relacionadas aos pacientes em tratamento 
dialítico. Rev Min Enf. 2006;10(2):145-150. 
3. Roy GC, Sutradhar SR, Barua UK, Datta NC, 
Debnath CR, Hoque MM, et al. Cardiovascular 
complications of chronic renal failure - an updated 
review. Mymensingh Med J. 2012;21(3):573-9. 
4. Marques AB, Pereira DC, Ribeiro RCHM. Motivos 
e frequência de internação dos pacientes com IRC 
em tratamento hemodialítico. Arq Ciênc Saúde. 
2005;12(2):67-72. 
5. Ribeiro RCHM, Oliveira GASA, Ribeiro DF, 
Bertolin DC, Cesarino CB, Lima LCEQ, et al. 
Caracterização e etiologia da insuficiência renal 
crônica em unidade de nefrologia do interior do 
Estado de São Paulo. Acta Paul Enferm. 2008;21(n. 
esp.):207-11. 
6. Nascimento CD, Marques IR. Intervenções de 
Enfermagem nas complicações mais frequentes 
durante a sessão de hemodiálise: revisão da 
literatura. Rev Bras Enferm. 2005;58(6):719-22. 
7. Sesso RCC, Lopes AA, Thomé FS, Lugon JR, 
Burdmann EZ. Brazilian Dialysis Census, 2009. J 
Bra Nefrol. 2010;32(4):380-4 
8. Castro MCM. Atualização em diálise: 
Complicações agudas em hemodiálise. J Bras 
Nefrol. 2001;23(2):108-13. 
9. Soares CB, Ochiro EY, Sannomiya NT. Relação 
da Temperatura da solução de hemodiálise e a 
hipotensão arterial sintomática observada durante 
sessões de hemodiálise em pacientes com 
insuficiência renal crônica. Rev Esc Enferm USP. 
2001;35(4):346-53. 
10. Saint-Remy A, Krzesinski JM. Optimal blood 
pressure level and best measurement procedure in 
hemodialysis patients. Vasc Health Risk Manag. 
2005;1(3):235–244. 
11. Carmo WB, Almeida SC, Rezende FCM, Oliveira 
VK, Henriques DMN, Andrade LC, et al. 
Hipertensão arterial e hipertrofia ventricular 
esquerda em pacientes renais crônicos em 
REFERENCES 
 
CONCLUSION 
 
ISSN 2175-5361                                                                                DOI: 10.9789/2175-5361.2013v5n2p3828  
                                                                                                                                                                                                                                                                                                         
Frota OP, Borges NMA                                                                             Hemodialysis Treatment-related… 
                                                   
R. pesq.: cuid. fundam. online 2013. abr./jun. 5(2):3828-36 
3835 
tratamento hemodialítico. J Bras Nefrol. 
2003;25(1):1-9. 
12. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, 
Greenland S, Kopple JD. Reverse Epidemiology of 
Hypertension and Cardiovascular Death in the 
Hemodialysis Population: The 58th Annual Fall 
Conference and Scientific Sessions. Hypertension. 
2005;45(2):811-17. 
13. Bzoma B, Slizień A, Dudziak M, Raczyńska K, 
Slizień W, Brylowska A, et al. Genetic 
predisposition to systemic complications of 
arterial hypertension in maintenance 
haemodialysis patients. Pol Merkur Lekarski. 
2008;25(147):209-16. 
14. Antonio Vukusich C, Alberto Fierro C, Jorge 
Morales B, Andrés Fantuzzi S, Cynthia Vukusich V, 
Jaime Mañalich M, et al. Epidemiología de la 
hipertensión en hemodiálisis crônica. Rev Méd 
Chile. 2002;130(6):610-15. 
15. Takeda A, Toda T, Fujii T, Shinohara S, Sasaki 
S, Matsui N. Discordance of influence of 
hypertension on mortality and cardiovascular risk 
in hemodialysis patients. Am J Kidney Dis. 
2005;45(1):112-8. 
16. Zoccali C, Benedetto FA, Tripepi G, Mallamaci 
F. Cardiac consequences of hypertension in 
hemodialysis patients. Semin Dial. 2004;17(4):299-
303. 
17. Moriya H, Ohtake T, Kobayashi S. Aortic 
stiffness, left ventricular hypertrophy and weekly 
averaged blood pressure (WAB) in patients on 
haemodialysis. Nephrol Dial Transplant. 
2007;22:1198–204. 
18. Petrović D, Stojimirović B. Cardiovascular 
morbidity and mortality in patients treated with 
hemodialysis - epidemiological analysis. 
Vojnosanit Pregl. 2008;65(12):893-900. 
19. Oliveira JMF. Revisão/Atualização em Diálise: 
Hipertensão arterial em hemodialisados. Fatores 
relacionados ao seu controle adequado ou 
inadequado e tratamento. J Bras Nefrol. 
1997;19(2):212-4. 
20. Veiga HC, Pinheiro LAF, Lugon JR. 
Revisão/Atualização em Diálise: Alterações 
cardiovasculares em pacientes em hemodiálise 
regular. J Bras Nefrol. 1998;20(3):336-41. 
21. Flores IP, Luño J. La insuficiencia renal es un 
importante factor de riesgo cardiovascular. 
Nefrología. 2002;22(4):306-9. 
22. Lima JJG. Practical ways to deal with the high 
burden of cardiovascular disease in hemodialysis 
patients. São Paulo Med J. 2006;124(1):36-41. 
23. Redmond A, McClelland H. Chronic kidney 
disease: risk factors, assessment and nursing care. 
Nursing Standard. 2006;20(10):48-55. 
24. Camelo SHH. Professional competences of 
nurse to work in Intensive Care Units: an 
integrative review. Rev Latino-am Enferm. 
2012;20(1):192-200. 
25. Souza MT, Silva MD, Carvalho R. Revisão 
integrativa: o que é e como fazer. Einstein. 
2010;8(1):102-6. 
26. Ursi ES. Prevenção de lesões de pele no 
perioperatório: revisão integrativa da literatura 
[Dissertação]. Ribeirão Preto (SP): Programa de 
Pós-Graduação Enfermagem Fundamental, 
Universidade de São Paulo; 2005.  
27. Abe S, Yoshizawa M, Nakanishi N, Yazawa T, 
Yokota K, Honda M, et al. Electrocardiographic 
abnormalities in patients receiving hemodialysis. 
Am Heart J. 1996;131(6):1137-44. 
28. Portoles J, Lopez-Gomez JM, Aljama P. 
Cardiovascular risk in hemodialysis in Spain: 
prevalence, management and target results (MAR 
study). Nefrología. 2005;25(3):297-306. 
29. Mitsnefes MM. Cardiovascular complications of 
pediatric chronic kidney disease. Pediatr Nephrol. 
2008;23(1):27–39. 
30. Ito S, Murai S, Sugiura M, Yoshida T, Fukutomi 
T. Predictors of Congestive Heart Failure in 
Patients on Maintenance Hemodialysis. Circ J. 
2007;71(9):1424–9. 
31. Switalski M, Kepka A, Galewicz M, Figatowski 
W, Maliński A. Ventricular arrhythmia in patients 
ISSN 2175-5361                                                                                DOI: 10.9789/2175-5361.2013v5n2p3828  
                                                                                                                                                                                                                                                                                                         
Frota OP, Borges NMA                                                                             Hemodialysis Treatment-related… 
                                                   
R. pesq.: cuid. fundam. online 2013. abr./jun. 5(2):3828-36 
3836 
with chronic renal failure treated with 
hemodialysis. Pol Arch Med Wewn. 
2000;104(4):703-8. 
32. Longenecker JC, Zubaid M, Johny KV, Attia AI, 
Ali J, Rashed W, et al. Association of Low Heart 
Rate Variability with Atherosclerotic 
Cardiovascular Disease in Hemodialysis Patients. 
Med Princ Pract. 2009;18(2):85–92. 
33. Harper CR, Jacobson TA. Managing 
Dyslipidemia in Chronic Kidney Disease. J Am Coll 
Cardiol. 2008;51(25):2375-84. 
34. Tanaka K, Tani Y, Asai J, Nemoto F, Kusano Y, 
Suzuki H, et al. Skin autofluorescence is 
associated with renal function and cardiovascular 
diseases in pre-dialysis chronic kidney disease 
patients. Nephrol Dial Transplant. 2011;26(1):214-
20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Received on: 16/07/2012 
Required for review: 30/01/2013 
Approved on: 27/02/2013 
Published on: 01/04/2013 
 
 
